Logo

Publikacije (48685)

Nazad
Z. Su, D. McDonnell, Xiaoshan Li, B. Bennett, S. Šegalo, Jaffar Abbas, A. Cheshmehzangi, Y. Xiang

Introduction: Vaccine inequality inflames the COVID-19 pandemic. Ensuring equitable immunization, vaccine empathy is needed to boost vaccine donations among capable countries. However, damaging narratives built around vaccine donations such as “vaccine diplomacy” could undermine nations’ willingness to donate their vaccines, which, in turn, further exacerbate global vaccine inequality. However, while discussions on vaccine diplomacy are on the rise, there is limited research related to vaccine diplomacy, especially in terms of its characteristics and effects on vaccine distribution vis-à-vis vaccine empathy. Thus, to bridge the research gap, this study aims to examine the defining attributes of vaccine diplomacy and its potential effects on COVID-19 immunization, particularly in light of vaccine empathy. Methods: A narrative review was conducted to shed light on vaccine diplomacy’s defining attributes and effects in the context of COVID-19 vaccine distribution and dissemination. Databases such as PubMed and Medline were utilized for literature search. Additionally, to ensure up-to-date insights are included in the review, validated reports and reverse tracing of eligible articles’ reference lists in Google Scholar have also been conducted to locate relevant records. Results: Vaccine empathy is an individual or a nation’s capability to sympathize with other individuals or nations’ vaccine wants and needs, whereas vaccine diplomacy is a nation’s vaccine efforts that aim to build mutually beneficial relationships with other nations ultimately. Our findings show that while both vaccine empathy and vaccine diplomacy have their strengths and weaknesses, they all have great potential to improve vaccine equality, particularly amid fast-developing and ever-evolving global health crises such as COVID-19. Furthermore, analyses show that, compared to vaccine empathy, vaccine diplomacy might be a more sustainable solution to improve vaccine donations mainly because of its deeper and stronger roots in multilateral collaboration and cooperation. Conclusion: Similar to penicillin, automated external defibrillators, or safety belts amid a roaring global health disaster, COVID-19 vaccines are, essentially, life-saving consumer health products that should be available to those who need them. Though man-made and complicated, vaccine inequality is nonetheless a solvable issue—gaps in vaccine distribution and dissemination can be effectively addressed by timely vaccine donations. Overall, our study underscores the instrumental and indispensable role of vaccine diplomacy in addressing the vaccine inequality issue amid the COVID-19 pandemic and its potentials for making even greater contributions in forging global solidarity amid international health emergencies. Future research could investigate approaches that could further inspire and improve vaccine donations among capable nations at a global scale to advance vaccine equity further.

Z. Su, A. Cheshmehzangi, D. McDonnell, S. Šegalo, J. Ahmad, Bindi Bennett

S. Shepherd, A. Fendler, L. Au, F. Byrne, K. Wilkinson, M. Wu, A. Schmitt, N. Joharatnam-Hogan et al.

Stefan Markovic, Nikolina Koporcic, Maja Arslanagić-Kalajdžić, Selma Kadic-Maglajlic, M. Bagherzadeh, Nazrul Islam

Abstract Small and medium-sized enterprises (SMEs) from emerging markets are the most vulnerable types of firms, especially in times of crisis due to time and resource constraints. Thus, this paper aims to help SMEs from emerging markets in choosing the right business partners with whom to cooperate to develop relevant innovations in crisis periods in general, and during the COVID-19 pandemic in particular. To obtain relevant insights, qualitative data from SMEs in Bosnia and Herzegovina were collected in March-April 2020. The findings show that SMEs have embraced new collaborations with business customers and competitors, and developed a collaborative mindset opposed to the traditionally competitive way of doing business in emerging markets. Based on the findings, this paper presents a set of recommendations for managers, and suggests several future research opportunities around the management of openness in the context of SMEs from emerging markets.

Predrag Ilić, S. Ilić, D. N. Markić, L. S. Bjelić, Z. Farooqi, Bhausaheb Sole, Narsimha Adimalla

Abstract Polycyclic aromatic hydrocarbons (PAHs) are formed from anthropogenic activities, i.e. industrial emissions, incomplete combustion of petroleum, coal and other fossil fuels and other industrial and domestic activities. Research areas of this study are four representative locations in the industrial complex, in the city of Banja Luka, Republic of Srpska, Bosnia and Herzegovina. The main objective of the paper is to determine the ecological risk and to assess probable sources of PAHs contamination in soil and groundwater. The results of this study reflect the effects of coal combustion (pyrogenic origin), petrogenic and biomass origin and may provide basic data for the remediation of PAHs in the location. The ecological risk in soil (at depths of 30, 100, 200, 300 and 400 cm) and groundwater is determined. The mean values of ecological risk in soil and groundwater decreased with soil depth. Values of RQ(NCs) for groundwater were found at high ecological risk, for Ant, Chr, DahA, Acy, Pyr, BaA, Phe, Flo, Nap, Ace and Fluo, with values 28.57, 20.59, 300.00, 242.86, 185.71, 1700.0, 76.67, 53.33, 15.83, 100.00 and 57.14, respectively. ∑16PAH indicated high ecological risk for most PAHs, which decreased with soil depth. The value of RQ(NCs) for ΣPAHs in groundwater indicates high ecological risk (ΣPAHs ≥ 800 and RQ(MPCs) ≥ 1). This is the first study on the ecological risk of PAHs in soil and groundwater in industrial soils in Banja Luka and provides baseline information for further studies and additional investigations of this industrial complex.

I. Sefah, D. Essah, M. Haque, S. Opanga, Santosh Kumar, Ibrahim Chikowe, D. Kibuule, E. Rampamba et al.

Introduction and Objectives: There have been concerns with the level of misinformation regarding coronavirus disease 2019 (COVID-19) and its treatment, drug shortages, as well as increased use and prices of anti-malarials, antibiotics and hygiene products during the recent pandemic. Community pharmacists can play a significant role in disease prevention and treatment in the fight against COVID-19 including providing hygiene information and medicine availability across Africa and generally. Consequently, there is a need to review the role of community pharmacists in preventing unintended consequences during any pandemic as well as the impact of COVID-19 on the demand, availability and prices of suggested medicines for its management. Materials and Methods: Multiple approaches involving a qualitative review of the management of COVID-19 across countries coupled with a pilot study in Ghana among six purposely selected community pharmacists during the early stages of the pandemic assessing patterns of demand, availability and prices of medicines suggested for the management of COVID-19. Alongside this, pharmacists' future role enhancing appropriate medicine use in Ghana and wider combined with the help of senior level co-authors. Results: The majority (five out of six) of pharmacists in Ghana reported increased demand for hydroxychloroquine, antibiotics and vitamins as immune boosters resulting in shortages with price increases particularly for anti-malarials. Conclusion: The global lockdown had impacted on the supply and prices of medicines in Ghana similar to other countries. Community pharmacists can play a key role with encouraging safe medicine use, reducing self-purchasing of medicines and planning workflows during future pandemics including vaccinations. They can also help address potential misinformation and its consequences as well as the unintended consequences of pandemics including better management of non-communicable diseases.

S. Rodrigo, S. Abadal, Eduard Alarcón, Medina Bandic, Hans van Someren, C. G. Almudever

Despite its tremendous potential, it is still unclear how quantum computing will scale to satisfy the requirements of its most powerful applications. Among other issues, there are hard limits to the number of qubits that can be integrated into a single chip. Multicore architectures are a firm candidate for unlocking the scalability of quantum processors. Nonetheless, the vulnerability and complexity of quantum communications make this a challenging approach. A comprehensive design should imply consolidating the communications stack in the quantum computer architecture. In this article, we explain how this vision, by entangling communications and computation in the core of the design, may help to solve the open challenges. We also summarize the first results of our application of structured design methodologies backing this vision. With our work, we hope to contribute with design guidelines that may help unleash the potential of quantum computing.

Mato Pavić, V. Premužić, Ana Zovak Pavic, M. Bevanda, S. Mihaljevic, S. Orešković

BACKGROUND Gestational diabetes mellitus (GDM) is the most common metabolic disorder in pregnancy. Pregnancies with GDM have worse outcomes compared to pregnancies with normal glucose tolerance. The objectives of the study were to determine the prevalence of GDM and perinatal outcomes according to the old WHO criteria and IADPSG criteria. SUBJECTS AND METHODS A retrospective study included 2,405 pregnant women who delivered between January 2009 and December 2010. According to the OGTT results, pregnant women were divided into 4 groups. We analyzed the prevalence of GDM, characteristics of pregnant women and their newborns and perinatal outcomes. RESULTS We found significantly higher prevalence of GDM according to the IADPSG criteria compared to the WHO criteria. Pregnant women with GDM were significantly older, had higher pre-pregnancy BMI, fasting and 2-h plasma glucose. Pregnant women with GDM had worse pregnancy outcomes compared to control group. The overall proportion of overweight and obese pregnant women was the highest in the group of untreated pregnant women with GDM according to the IADPSG criteria. In this group we found significantly higher rate of fetal macrosomia and LGA. The rate of caesarean section was significantly higher in comparison to control group. Pre-eclampsia was significantly more common in groups of pregnant women with GDM compared to control group. CONCLUSION IADPSG diagnostic criteria reveals more women with hyperglycemic disorders in pregnancy. A group of pregnant women who were normoglycemic according to the WHO criteria, but according to the IADPSG were diagnosed GDM, had adverse pregnancy outcomes. Lower values of glycemia, than those defined for diabetes in pregnancy, are associated with adverse pregnancy outcomes.

Ivona Ljevak, I. Vasilj, Josip Lesko, M. Neuberg, Olivera Perić, Marina Ćurlin

SUMMARY Providing in-patient nursing care inevitably involves shift work and shift patterns have been identified as an important factor in determining well-being and satisfaction among nurses. Shifts of 12 h or longer have become increasingly common for nurses in hospitals in some European countries. Longer shifts offer a potential to benefit from a compressed working week, with fewer work days and more days off-work, lower commuting costs, and increased flexibility. Most people find shift work less desirable compared to standard working hours. A cross-sectional cohort study was conducted at the Mostar University Hospital in 2019. A total of 157 subjects participated in the study, 22 (14%) of which were male (medical technicians) and 135 (86%) female (nurses). The mean age of study subjects was 33.3 years (min=20, max=54, SD=8.033). Results of this study suggested that nurses working irregular rotating shifts, with more family members to look after and more than 18 years of professional experience were affected by sleep disturbances between shifts. The study showed that shift work nurses had significantly higher levels of cortisol and prolactin compared with first-shift nurses/medical technicians. The results of this study are expected to stimulate further studies of sleep disturbances among shift nurses.

J. Šupić, E. Rešidbegović, A. Koro, S. Hadžiabdić, M. Golob, V. Škapur, A. Alić

Abstract Infections with various bacteria, especially gram-negative aerobes, are a well-recognized problem in captive cold-blooded animals with immunocompromised health status, or in those kept under poor conditions. Pseudomonas is one of the most represented genera. Here, we present a case of fatal disseminated infection caused by Pseudomonas aeruginosa in a captive green iguana kept at the “Pionirska dolina” Zoo in Sarajevo, Bosnia and Herzegovina. At necropsy, severe stomatitis, pneumonia, hepatitis and nephritis, accompanied with focally extensive dermatitis were observed. Histopathology revealed multifocal necrosis in various visceral organs. Culture and subsequent MALDI-TOF MS analysis were conducted to identify the isolate as P. aeruginosa. Antimicrobial susceptibility testing revealed a wide susceptibility of the isolate, however applied therapy was instilled too late in the presented case. This case demonstrates the significance of timely and accurate identification, and antimicrobial susceptibility testing of bacterial isolates implicated in the pathology of captive reptiles. The importance of monitoring the adequate environmental conditions (enclosure temperature, humidity and conformation), health status and possible clinical signs of illness are highlighted.

S. Shepherd, A. Fendler, L. Au, F. Byrne, K. Wilkinson, M. Wu, A. Schmitt, N. Joharatnam-Hogan et al.

Background: Patients with cancer are at increased risk of severe outcomes from COVID-19. Understanding the impact of SARS-CoV-2 infection and vaccination induced-immunity is an area of unmet need. Methods: CAPTURE (NCT03226886) is a prospective longitudinal cohort study of COVID-19 vaccine or SARS-CoV-2 infection-induced immunity. SARS-CoV-2 infections were con fi rmed by RT-PCR and ELISA. Neutralising antibody titres (NAbT) against wild- type (WT) SARS-CoV-2 and variants of concern (VOC; Alpha, Beta, Delta) and SARS-CoV-2 speci fi c T-cells (SsT-cells) ed. Results: 118 patients (89% solid malignancy, [SM]) were SARS-CoV-2-positive (median follow-up: 154 days). 85% patients were symptomatic; 2 died of COVID-19. 82% had S1-reactive antibodies, of whom 89% had neutralising antibodies (NAbs); NAbT were lower against all VOCs. While S1-reactive antibody levels declined over time, NAbT remained stable up to 329 days. Most patients had detectable SsT-cells (76% CD4+, 52% CD8+). Haematological malignancy (HM) patients had impaired immune responses that were disease and treatment-speci fi c (anti-CD20), but with evidence suggestive of compensation from T-cells. 585 patients were evaluated following 2 doses of BNT162b2 or AZD1222 vaccines, administered 12 weeks apart. Serocon- version rates after 2 doses were 85% and 54% in patients with SM and HM, respectively. A lower proportion of patients had detectable NAbs against SARS-CoV-2 VOC (Alpha 62%, Beta 54%, Delta 49%) vs WT (84%), with corresponding signi fi cantly lower NAbT. Patients with HM were more likely to have an undetectable NAb and had lower NAbT vs solid malignancies to both WT and VOCs. Seroconversion showed poor concordance with NAbTs against VOCs. Prior SARS-CoV-2 infection boosted NAbT including against VOCs. Anti-CD20 treatment was associated with severely diminished NAbTs. Vaccine-induced T-cell responses were detected in 80% of patients, with no differences between vaccines or cancer types. Conclusions: Patients with HM had blunted humoural responses to infection and vaccination, particularly against VOCs, but preserved cellular responses might contribute to protection. Our results lend support to prioritisation of all cancer pa- tients for further booster vaccination. Background: Patients with cancer are at higher risk of developing COVID-19 disease, adverse outcomes, and increased mortality. Phase III COVID-19 vaccine trials have demonstrated safety/ef fi cacy against COVID-19 and prevented hospitalizations and deaths; however, most excluded ptcpts with cancer.We present phase 3 tozinameran mRNA COVID-19 vaccine trial results from ptcpts with a cancer history at baseline, either ongoing or not, per the Charlson Comorbidity Index and up to 6 months

F. Vanhuyse, Emir Fejzic, Daniel Ddiba, Maryna Henrysson

Abstract Worldwide, cities are implementing circular economy (CE) strategies to reduce the resources they consume and their environmental impact. However, the evidence of the intended and unintended social consequences of the transition to “circular cities” is scattered. The lack of a coherent overview of the evidence on the subject can hinder effective decision-making in policy and practice. This study examines the extent to which the current literature addresses the social impacts that a transition to a CE produces in cities. We used a methodological approach related to systematic mapping to collate the evidence published over the past decade globally. The study finds that social impacts have rarely been considered in studies of circular cities, and where they have been discussed, the scope has been quite limited, only covering employment (mostly of informal sector workers) and governance practices. This scoping review highlights the need to further analyse and integrate social impact considerations into decision-making connected to transitions towards circular cities.

Nema pronađenih rezultata, molimo da izmjenite uslove pretrage i pokušate ponovo!

Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više